{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:22:51Z","timestamp":1789050171777,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the \u201cKuncheng Talents\u201d Project of Changshu Medical and Health Science and Technology Plan","award":["KCH202301"],"award-info":[{"award-number":["KCH202301"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31772593"],"award-info":[{"award-number":["31772593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20191476"],"award-info":[{"award-number":["BK20191476"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96848-0","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T12:07:04Z","timestamp":1760443624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect and mechanism of fisetin against the development of metabolic dysfunction-associated fatty liver disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Xin","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luojie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"4","key":"96848_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"European association for the study of the l, European association for the study of D, European association for the study of O","year":"2024","unstructured":"European association for the study of the l, European association for the study of D, European association for the study of O. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts 17(4), 374\u2013444 (2024).","journal-title":"Obes Facts"},{"issue":"1","key":"96848_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73(1), 202\u2013209 (2020).","journal-title":"J. Hepatol."},{"issue":"3","key":"96848_CR3","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1097\/HEP.0000000000000696","volume":"79","author":"JV Lazarus","year":"2024","unstructured":"Lazarus, J. V. et al. Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 79(3), E93\u2013E94 (2024).","journal-title":"Hepatology"},{"issue":"2","key":"96848_CR4","doi-asserted-by":"publisher","first-page":"e100019","DOI":"10.1136\/egastro-2023-100019","volume":"1","author":"M Eslam","year":"2023","unstructured":"Eslam, M. & George, J. Two years on, a perspective on MAFLD. eGastroenterology 1(2), e100019 (2023).","journal-title":"eGastroenterology"},{"issue":"10319","key":"96848_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","volume":"399","author":"TH Karlsen","year":"2022","unstructured":"Karlsen, T. H. et al. The EASL-lancet liver commission: Protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 399(10319), 61\u2013116 (2022).","journal-title":"Lancet"},{"issue":"6","key":"96848_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol. Int. 14(6), 889\u2013919 (2020).","journal-title":"Hepatol. Int."},{"issue":"1","key":"96848_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek, J. et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 8(1), 20\u201330 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"8","key":"96848_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8), 1038\u20131048 (2016).","journal-title":"Metabolism"},{"issue":"2","key":"96848_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","volume":"10","author":"JC Arroyave-Ospina","year":"2021","unstructured":"Arroyave-Ospina, J. C. et al. Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: Implications for prevention and therapy. Antioxidants (Basel) 10(2), 174 (2021).","journal-title":"Antioxidants (Basel)"},{"issue":"11","key":"96848_CR10","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/antiox11112190","volume":"11","author":"Z Zakaria","year":"2022","unstructured":"Zakaria, Z. et al. Therapeutic effects of Heterotrigona itama (stingless bee) bee bread in improving hepatic lipid metabolism through the activation of the Keap1\/Nrf2 signaling pathway in an obese rat model. Antioxidants (Basel) 11(11), 2190 (2022).","journal-title":"Antioxidants (Basel)"},{"key":"96848_CR11","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.12659\/MSM.907530","volume":"23","author":"H Fan","year":"2017","unstructured":"Fan, H. et al. Scutellarin prevents nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia via PI3K\/AKT-dependent activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in rats. Med. Sci. Monit. 23, 5599\u20135612 (2017).","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"96848_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","volume":"5","author":"RS Sharma","year":"2018","unstructured":"Sharma, R. S. et al. Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-related factor 2). Cell. Mol. Gastroenterol. Hepatol. 5(3), 367\u2013398 (2018).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"96848_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2017.04.021","volume":"806","author":"X Sun","year":"2017","unstructured":"Sun, X. et al. Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice. Eur. J. Pharmacol. 806, 75\u201382 (2017).","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"96848_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","volume":"69","author":"VW Wong","year":"2018","unstructured":"Wong, V. W. et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J. Hepatol. 69(6), 1349\u20131356 (2018).","journal-title":"J. Hepatol."},{"key":"96848_CR15","doi-asserted-by":"publisher","first-page":"113535","DOI":"10.1016\/j.ejmech.2021.113535","volume":"221","author":"C Villarroel-Vicente","year":"2021","unstructured":"Villarroel-Vicente, C. et al. Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview. Eur. J. Med. Chem. 221, 113535 (2021).","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"96848_CR16","doi-asserted-by":"publisher","first-page":"e21226","DOI":"10.1371\/journal.pone.0021226","volume":"6","author":"P Maher","year":"2011","unstructured":"Maher, P. et al. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. PLoS ONE 6(6), e21226 (2011).","journal-title":"PLoS ONE"},{"key":"96848_CR17","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.biopha.2018.07.079","volume":"106","author":"P Mehta","year":"2018","unstructured":"Mehta, P. et al. Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine. Biomed. Pharmacother. 106, 1282\u20131291 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"96848_CR18","doi-asserted-by":"publisher","first-page":"107353","DOI":"10.1016\/j.intimp.2020.107353","volume":"92","author":"G Chenxu","year":"2021","unstructured":"Chenxu, G. et al. Fisetin protects against high fat diet-induced nephropathy by inhibiting inflammation and oxidative stress via the blockage of iRhom2\/NF-kappaB signaling. Int. Immunopharmacol. 92, 107353 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"96848_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.neuint.2018.05.011","volume":"118","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Fisetin alleviates oxidative stress after traumatic brain injury via the Nrf2-ARE pathway. Neurochem. Int. 118, 304\u2013313 (2018).","journal-title":"Neurochem. Int."},{"key":"96848_CR20","doi-asserted-by":"publisher","first-page":"549037","DOI":"10.3389\/fnins.2020.549037","volume":"14","author":"TJ Chen","year":"2020","unstructured":"Chen, T. J. et al. Fisetin regulates gut microbiota and exerts neuroprotective effect on mouse model of Parkinson\u2019s disease. Front. Neurosci. 14, 549037 (2020).","journal-title":"Front. Neurosci."},{"issue":"8","key":"96848_CR21","doi-asserted-by":"publisher","first-page":"12762","DOI":"10.1002\/jcb.28544","volume":"120","author":"HH Gaballah","year":"2019","unstructured":"Gaballah, H. H., El-Horany, H. E. & Helal, D. S. Mitigative effects of the bioactive flavonol fisetin on high-fat\/high-sucrose induced nonalcoholic fatty liver disease in rats. J. Cell. Biochem. 120(8), 12762\u201312774 (2019).","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"96848_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/biom9090430","volume":"9","author":"RK Al-Ishaq","year":"2019","unstructured":"Al-Ishaq, R. K. et al. Flavonoids and their anti-diabetic effects: Cellular mechanisms and effects to improve blood sugar levels. Biomolecules 9(9), 430 (2019).","journal-title":"Biomolecules"},{"key":"96848_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejphar.2014.06.065","volume":"740","author":"GS Prasath","year":"2014","unstructured":"Prasath, G. S., Pillai, S. I. & Subramanian, S. P. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats. Eur. J. Pharmacol. 740, 248\u2013254 (2014).","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"96848_CR24","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1039\/C8FO01615A","volume":"10","author":"M Xu","year":"2019","unstructured":"Xu, M. et al. Activated TNF-alpha\/RIPK3 signaling is involved in prolonged high fat diet-stimulated hepatic inflammation and lipid accumulation: Inhibition by dietary fisetin intervention. Food Funct. 10(3), 1302\u20131316 (2019).","journal-title":"Food Funct."},{"key":"96848_CR25","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673342421241126060049","author":"M Sattari","year":"2025","unstructured":"Sattari, M. et al. Improving non-alcoholic fatty liver disease treatment in high-fat diet fed mice with fisetin and hydroxychloroquine: The cooperative pathways for improved metabolic health. Curr. Med. Chem. https:\/\/doi.org\/10.2174\/0109298673342421241126060049 (2025).","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"96848_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","volume":"26","author":"S Raza","year":"2021","unstructured":"Raza, S. et al. Current treatment paradigms and emerging therapies for NAFLD\/NASH. Front. Biosci. (Landmark Ed) 26(2), 206\u2013237 (2021).","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"Suppl 4","key":"96848_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jgh.12244","volume":"28","author":"JG Fan","year":"2013","unstructured":"Fan, J. G. & Cao, H. X. Role of diet and nutritional management in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 28(Suppl 4), 81\u201387 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"96848_CR28","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1039\/C8FO01653D","volume":"10","author":"C Ge","year":"2019","unstructured":"Ge, C. et al. Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation. Food Funct. 10(5), 2970\u20132985 (2019).","journal-title":"Food Funct."},{"key":"96848_CR29","doi-asserted-by":"publisher","first-page":"108253","DOI":"10.1016\/j.jnutbio.2019.108253","volume":"77","author":"LF Hu","year":"2020","unstructured":"Hu, L. F. et al. Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling. J. Nutr. Biochem. 77, 108253 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"96848_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2019.05.031","volume":"141","author":"CX Ge","year":"2019","unstructured":"Ge, C. X. et al. Endoplasmic reticulum stress-induced iRhom2 up-regulation promotes macrophage-regulated cardiac inflammation and lipid deposition in high fat diet (HFD)-challenged mice: Intervention of fisetin and metformin. Free Radic. Biol. Med. 141, 67\u201383 (2019).","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"96848_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00011-020-01373-7","volume":"69","author":"Ekta","year":"2020","unstructured":"Ekta, et al. Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease. Inflamm. Res. 69(9), 851\u2013867 (2020).","journal-title":"Inflamm. Res."},{"issue":"1","key":"96848_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12944-018-0920-4","volume":"17","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population: A secondary analysis based on a cross-sectional study. Lipids Health Dis. 17(1), 275 (2018).","journal-title":"Lipids Health Dis."},{"issue":"3","key":"96848_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini, E. G., Testa, R. & Savarino, V. Liver enzyme alteration: A guide for clinicians. CMAJ 172(3), 367\u2013379 (2005).","journal-title":"CMAJ"},{"issue":"9","key":"96848_CR34","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/D0FO02736G","volume":"12","author":"J Li","year":"2021","unstructured":"Li, J. et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct. 12(9), 3898\u20133918 (2021).","journal-title":"Food Funct."},{"issue":"1","key":"96848_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: A revolutionary tool for transcriptomics. Nat. Rev. Genet. 10(1), 57\u201363 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"96848_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fmed.2018.00192","volume":"5","author":"N Oliva-Vilarnau","year":"2018","unstructured":"Oliva-Vilarnau, N. et al. Calcium signaling in liver injury and regeneration. Front. Med. (Lausanne) 5, 192 (2018).","journal-title":"Front. Med. (Lausanne)"},{"key":"96848_CR37","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.2147\/DDDT.S108539","volume":"10","author":"J Runtuwene","year":"2016","unstructured":"Runtuwene, J. et al. Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4. Drug Des. Devel. Ther. 10, 2193\u20132202 (2016).","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"96848_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/JCI10294","volume":"108","author":"JK Kim","year":"2001","unstructured":"Kim, J. K. et al. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J. Clin. Invest. 108(1), 153\u2013160 (2001).","journal-title":"J. Clin. Invest."},{"key":"96848_CR39","first-page":"101168","volume":"28","author":"T Yasmin","year":"2021","unstructured":"Yasmin, T. et al. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways. Biochem. Biophys. Rep. 28, 101168 (2021).","journal-title":"Biochem. Biophys. Rep."},{"key":"96848_CR40","doi-asserted-by":"publisher","first-page":"154000","DOI":"10.1016\/j.metabol.2019.154000","volume":"102","author":"WC Sim","year":"2020","unstructured":"Sim, W. C. et al. Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease. Metabolism 102, 154000 (2020).","journal-title":"Metabolism"},{"issue":"6","key":"96848_CR41","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/2211-5463.12429","volume":"8","author":"M Hamano","year":"2018","unstructured":"Hamano, M. et al. Enhanced vulnerability to oxidative stress and induction of inflammatory gene expression in 3-phosphoglycerate dehydrogenase-deficient fibroblasts. FEBS Open Bio 8(6), 914\u2013922 (2018).","journal-title":"FEBS Open Bio"},{"key":"96848_CR42","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12058","author":"H Huang","year":"2021","unstructured":"Huang, H. et al. Phgdh serves a protective role in Il-1beta induced chondrocyte inflammation and oxidative-stress damage. Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12058 (2021).","journal-title":"Mol. Med. Rep."},{"key":"96848_CR43","doi-asserted-by":"publisher","first-page":"990551","DOI":"10.3389\/fonc.2023.990551","volume":"13","author":"Q Hu","year":"2023","unstructured":"Hu, Q. et al. GPX3 expression was down-regulated but positively correlated with poor outcome in human cancers. Front. Oncol. 13, 990551 (2023).","journal-title":"Front. Oncol."},{"issue":"6","key":"96848_CR44","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/antiox10060903","volume":"10","author":"JY Hsu","year":"2021","unstructured":"Hsu, J. Y. et al. Aqueous extract of pepino leaves ameliorates palmitic acid-induced hepatocellular lipotoxicity via inhibition of endoplasmic reticulum stress and apoptosis. Antioxidants (Basel) 10(6), 903 (2021).","journal-title":"Antioxidants (Basel)"},{"key":"96848_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2015.08.032","volume":"765","author":"L Li","year":"2015","unstructured":"Li, L. et al. Herbacetin inhibits inducible nitric oxide synthase via JNK and nuclear factor-kappaB in LPS-stimulated RAW264.7 cells. Eur. J. Pharmacol. 765, 115\u2013123 (2015).","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"96848_CR46","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3892\/mmr.2016.5393","volume":"14","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-kappaB in mice fed a high-fat diet. Mol. Med. Rep. 14(2), 1323\u20131331 (2016).","journal-title":"Mol. Med. Rep."},{"key":"96848_CR47","doi-asserted-by":"publisher","first-page":"105667","DOI":"10.1016\/j.biocel.2019.105667","volume":"119","author":"H Hosseini","year":"2020","unstructured":"Hosseini, H. et al. Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway. Int. J. Biochem. Cell. Biol. 119, 105667 (2020).","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"2","key":"96848_CR48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/10715762.2017.1422602","volume":"52","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARgamma\/PGC-1alpha-Nrf2 pathway. Free Radic. Res. 52(2), 198\u2013211 (2018).","journal-title":"Free Radic. Res."},{"key":"96848_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.redox.2018.07.002","volume":"18","author":"XJ Zhao","year":"2018","unstructured":"Zhao, X. J. et al. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1\/Nrf2 pathway. Redox Biol. 18, 124\u2013137 (2018).","journal-title":"Redox Biol."},{"key":"96848_CR50","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3389\/fphar.2020.00944","volume":"11","author":"NJ Roos","year":"2020","unstructured":"Roos, N. J. et al. Lapatinib activates the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 pathway in HepG2 cells. Front. Pharmacol. 11, 944 (2020).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"96848_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/gutjnl-2013-306043","volume":"64","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y. et al. Therapeutic targeting of GSK3beta enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C. Gut 64(1), 168\u2013179 (2015).","journal-title":"Gut"},{"issue":"5","key":"96848_CR52","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jceh.2018.10.004","volume":"9","author":"O Bedi","year":"2019","unstructured":"Bedi, O. et al. Molecular and pathological events involved in the pathogenesis of diabetes-associated nonalcoholic fatty liver disease. J. Clin. Exp. Hepatol. 9(5), 607\u2013618 (2019).","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"19\u201320","key":"96848_CR53","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.lfs.2008.01.022","volume":"82","author":"WN Cong","year":"2008","unstructured":"Cong, W. N. et al. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Life Sci. 82(19\u201320), 983\u2013990 (2008).","journal-title":"Life Sci."},{"issue":"6","key":"96848_CR54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmet.2009.10.007","volume":"10","author":"DM Erion","year":"2009","unstructured":"Erion, D. M. et al. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metab. 10(6), 499\u2013506 (2009).","journal-title":"Cell Metab."},{"issue":"3","key":"96848_CR55","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1039\/D0FO02387F","volume":"12","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis via activating the PI3K\/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes. Food Funct. 12(3), 1207\u20131218 (2021).","journal-title":"Food Funct."},{"issue":"21","key":"96848_CR56","doi-asserted-by":"publisher","first-page":"11838","DOI":"10.3390\/ijms222111838","volume":"22","author":"R Nawrot","year":"2021","unstructured":"Nawrot, R. et al. Combined protein and alkaloid research of chelidonium majus latex reveals CmMLP1 accompanied by alkaloids with cytotoxic potential to human cervical carcinoma cells. Int. J. Mol. Sci. 22(21), 11838 (2021).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96848-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96848-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96848-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:18:31Z","timestamp":1760455111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96848-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96848"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96848-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures and protocols in this study were approved by the Animal Care Committee of the Changshu Institute of Technology (Permit number: EAWEC202209). The study is reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"35766"}}